logo

REPL’s Stock Market Adventure: 41.16% YTD Growth Amidst Volatility

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price gain of 41.16% this year. Over the last six months, there has been a weaker performance of 66.90%. The price of REPL fallen by 17.01% during the last 30 days period. For the last 5-days stocks have improved 7.50%.

Replimune Group Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $17.01 on 10/02/23, while the lowest price during the same period was $4.92 on 05/29/24.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

52-week price history of REPL Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Replimune Group Inc’s current trading price is -30.04% away from its 52-week high, while its distance from the 52-week low is 141.87%. The stock’s price range over this timeframe has been between $4.92 and $17.01. The shares of the Healthcare sector company recorded a trading volume of approximately 1.24 million for the day, which was comparatively higher than the average daily volume of 0.68 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Replimune Group Inc (REPL) has experienced a quarterly rise of 42.17% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 813.01M and boasts a workforce of 331 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 9.09, with a change in price of +5.22. Similarly, Replimune Group Inc recorded 998,865 in trading volume during the last 100 days, posting a change of +78.14%.

REPL’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for REPL stands at 0.18. Similarly, the long-term debt-to-equity ratio is also 0.17.

REPL Stock Stochastic Average

Replimune Group Inc’s raw stochastic average for the past 50 days is currently at 99.65%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 99.45%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 75.22% and 69.57%, respectively.

Most Popular